Timber Pharmaceuticals Inc 's

• TMBR's Stock Performance relative to its Competitors

Sarepta Therapeutics Inc Share Performance -11.20% Over The Past 5 Days

Sarepta Therapeutics Inc Profile Sarepta Therapeutics Inc's business model centers around the research, development, and commercialization of innovative genetic medicines for rare diseases, with a particular focus on Duchenne muscular dystrophy (DMD). More about Sarepta Therapeutics Inc 's Market Share

Royalty Pharma Plc Share Performance +61.44% One Year

Royalty Pharma Plc Profile Royalty Pharma Plc operates as a pharmaceutical investment company, focusing on acquiring and managing royalty interests in approved drugs. Their business model primarily revolves around purchasing existing royalty streams in exchange for upfront payments, allowing them to generate ongoing cash flows from the sales of these drugs. They aim to provide liquidity to stakeholders, such as biotech and pharmaceutical companies, by offering a financial alternative to traditional financing options. More about Royalty Pharma Plc's Market Share

Renovorx Inc Share Performance +101.16% This Quarter

Renovorx Inc Profile Renovorx Inc is a medical technology company specializing in the development of innovative treatments for cardiovascular diseases. Their business model focuses on creating and commercializing minimally invasive therapies for patients suffering from conditions like myocardial infarction and heart failure. By leveraging cutting-edge medical devices and procedures, Renovorx aims to provide effective and efficient treatments that can significantly improve patient outcomes and quality of life. More about Renovorx Inc 's Market Share

Ventyx Biosciences Inc Share Performance +66.31% This Year

Ventyx Biosciences Inc Profile Ventyx Biosciences Inc is a biotechnology company that follows a research and development-focused business model. It aims to develop innovative biopharmaceutical products and therapeutic solutions by leveraging its expertise in various fields such as genetic engineering, drug discovery, and clinical trials. The company seeks to form strategic partnerships and licensing agreements to accelerate the commercialization of its products. More about Ventyx Biosciences Inc 's Market Share

Protokinetix Incorporated Share Performance -96.23% This Quarter

Protokinetix Incorporated Profile Protokinetix Incorporated's business model revolves around the commercialization of its proprietary technology, AAGP™ (Antifreeze Protein Analog). More about Protokinetix Incorporated's Market Share

Sources: Timber Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 8:16 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Timber Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.